β-sitosterol induces G1 arrest and causes depolarization of mitochondrial membrane potential in breast carcinoma MDA-MB-231 cells

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Vundru, Shanthi S ^a   Kale, Raosaheb K ^a,b   Singh, Rana P ^a,b  

^a CENTRAL UNIVERSITY OF GUJARAT   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Breast cancer; Cell cycle and apoptosis; Cell death; Cell proliferation; Lung cancer; Skin cancer

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BAX; PROTEIN BCL 2; SITOSTEROL;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA; CARCINOMA CELL; CELL ASSAY; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; FLUORESCENCE ACTIVATED CELL SORTING; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; LUNG CARCINOMA; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; SITOSTEROLS;

EID: 84886147806     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-280     Document Type: Article

References (36)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. Estimates of worldwide burden of cancer in 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516, 21351269.
2. American Cancer Society Cancer Facts and Figures: 2010 2010, 1-62. Atlanta: American Cancer Society, American Cancer Society.
3. Anne S, Tsao M, Edward S, Kim M, Waun Ki Hong M. Chemoprevention of cancer. Am Cancer J Clin 2004, 54:150-180.
4. Nishino H, Tokuda H, Satomi Y, Masuda M, Onozuka M, Yamaguchi S, Takayasu J. Cancer chemoprevention by phytochemicals and their related compounds. Asian Pacific J Cancer 2000, 1:49-55.
5. Dragsted L, Strube M, Larsen J. Cancer-protective factors in fruits and vegetables: biochemical and biological background. Pharmacol Toxicol 1993, 72:116-135.
6. Demirkol O, Adams C, Ercal N. Biologically important thiols in various vegetables and fruits. J Agric Food Chem 2004, 52:8151-8154. 10.1021/jf040266f, 15612810.
7. Chandra S, Sah K, Bagewadi A, Keluskar V, Shetty A. Additive and synergistic effect of phytochemicals in prevention of oral cancer. Eur J Gen Dent 2012, 1:142-147.
8. Valsta L, Lemström A, Ovaskainen M, Lampi A, Toivo J, Korhonen T, Piironen V. Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake. Br J Nutr 2007, 92:671-678.
9. Trautwein E, Lin Y, Mel S, Molhuizen H, Ntanios F. Proposed mechanisms of cholesterol-lowering action of plant sterols. Eur J Lipid Sci Technol 2003, 105:171-185.
10. Bouic P, Lamprecht J. Plant Sterols and Sterolins: A review of their Immune-modulating properties sterols & sterolins. Altern Med Rev 1999, 4:170-177.
11. Awad A, Chinnam M, Fink C, Bradford P. Beta-Sitosterol activates Fas signaling in human breast cancer cells. Phytomedicine 2007, 14:747-754. 10.1016/j.phymed.2007.01.003, 17350814.
12. Awad A, Burr A, Fink C. Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells. Prostaglandins Leukot Essent Fat Acids 2005, 72:219-226.
13. Von Holtz R, Fink C, Awad A. Beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer 1998, 32:8-12. 10.1080/01635589809514709, 9824850.
14. Bhat TA, Nambiar D, Pal A, Agarwal R, Singh RP. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo-implications for angioprevention. Carcinog 2012, 33:385-393.
15. Yim D, Singh RP, Agarwal C, Lee S, Chi H. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res 2005, 65:1035-1044.
16. Luo KW, Sun JG, Chan JY, Yang L, Wu SH, et al. Anticancer effects of imperatorin isolated from Angelica dahurica: induction of apoptosis in HepG2 cells through both death-receptor- and mitochondria-mediated pathways. Chemother 2011, 57:449-459.
17. Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003, 22:8271-8282. 10.1038/sj.onc.1207158, 14614451.
18. Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R. Silibinin efficacy against human hepatocellular carcinoma. Clin Cancer Res 2005, 11:8441-8448. 10.1158/1078-0432.CCR-05-1646, 16322307.
19. Sheu MJ, Huang GJ, Wu CH, Chen JS, Chang HY, Chang SJ, Chang JG. Ethanol extract of Dunaliella salina induces cell cycle arrest and apoptosis in A549 human non-small cell lung cancer cells. In Vivo 2004, 212:369-378.
20. Singh T, Sharma SD, Katiyar SK. Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo. PLoS One 2011, 6:e27444. 10.1371/journal.pone.0027444, 3210794, 22087318.
21. Kakizoe T. Chemoprevention of cancer - focusing on clinical trials. Japanese J Clin Oncol 2003, 33:421-442.
22. Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene 2006, 25:1053-1069. 10.1038/sj.onc.1209146, 16205633.
23. Kastan MB, Canman CE, Leonard CJ. P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995, 14:3-15. 10.1007/BF00690207, 7606818.
24. Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle 2002, 1:103-110.
25. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995, 10:775-778.
26. Dong Y, Sui L, Sugimoto K, Tai Y, Tokuda M. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int J Cancer 2001, 95:209-215. 10.1002/1097-0215(20010720)95:4<209::AID-IJC1036>3.0.CO;2-R, 11400112.
27. Wu A, Wu B, Guo J, Luo W, Wu D, Yang H, Zhen Y, et al. Elevated expression of CDK4 in lung cancer. J Transl Med 2011, 9:1-9.
28. Lantsov D, Meirmanov S, Nakashima M, Kondo H, Saenko V, Naruke Y, Namba H. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression. Histopathol 2005, 47:248-256.
29. Singh RP, Agarwal R. Flavonoid antioxidant silymarin and skin cancer. Antioxid Redox Signal 2002, 4:655-663. 10.1089/15230860260220166, 12230878.
30. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, Aaronson SA. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 1999, 18:2789-2797. 10.1038/sj.onc.1202615, 10362249.
31. Polyak K, Lee MH, Erdjument BH, Koff A, Roberts JM, Tempst P, Massagué J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66. 10.1016/0092-8674(94)90572-X, 8033212.
32. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW. p27/kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999, 154:313-323. 10.1016/S0002-9440(10)65277-7, 1850003, 10027389.
33. Osborne C, Wilson P, Tripathy D. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 2004, 9:361-377. 10.1634/theoncologist.9-4-361, 15266090.
34. Singh RP, Agarwal C, Agarwal R. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Carcinog 2003, 24:555-563.
35. Cory S, Huang DCS, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003, 22:8590-8607. 10.1038/sj.onc.1207102, 14634621.
36. Katiyar SK, Roy AM, Baliga MS. Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol Cancer Ther 2005, 4:207-216. 10.4161/cbt.4.2.1442, 15713892.